Chronic myeloid leukaemia
A rare, slow-growing cancer of the bone marrow and of the white blood cells it makes.1 Early on there may be no symptoms; later it can cause tiredness, night sweats, weight loss and a swollen tummy.2 The main treatment is targeted medicines called tyrosine kinase inhibitors, which aim to stop the cancer growing.3 It can start at any age but is more common from about 65.1
Read more about Chronic myeloid leukaemiaTrial-stage treatments and research studies you can join
Filters
- Cladribine, idarubicin, cytarabine and venetoclax for acute myeloid leukemia and related blood cancers
Tests chemotherapy with venetoclax in adults with acute myeloid leukemia and related cancers.
Houston, United StatesAge 18 to 65 - Testing the safety of agenT-797 cells after a stem cell transplant for blood cancers
Tests whether agenT-797 is safe for adults after a donor stem cell transplant.
Madison, United StatesAge 18+ - Tests blinatumomab with chemotherapy and ponatinib in adults with leukemia
Tests blinatumomab, chemotherapy and ponatinib in adults with Philadelphia-positive acute lymphoblastic leukemia.
Houston, United StatesAge 18+ - Testing dexrazoxane to protect the heart during chemotherapy for blood cancers
Tests dexrazoxane to reduce heart side effects of chemotherapy in people with blood cancers.
Houston, United StatesAge 12+ - Tests asciminib in children with chronic myeloid leukemia
Tests asciminib in children aged 1 to under 18 with Ph+ chronic myeloid leukemia.
Chicago, United StatesAlso Cincinnati, New Brunswick, New York, SeattleAge 1 to 18 - Long-term asciminib treatment for people with chronic myeloid leukemia
Tests asciminib long term in people with chronic myeloid leukemia who finished an earlier study.
Ann Arbor, United StatesAlso Cincinnati, Dallas, Houston, Milwaukee, New York, Portland, Salt Lake City, St LouisAge 7 to 100 - Axatilimab With or Without Azacitidine for Advanced Blood Cancers of the Bone Marrow
Tests axatilimab, alone or with azacitidine, in adults with advanced blood and bone marrow cancers.
Columbus, United StatesAlso PortlandAge 18+ - Ropeginterferon alfa-2b for chronic myelomonocytic leukemia and related overlap blood cancers
Tests ropeginterferon alfa-2b in adults with chronic myelomonocytic leukemia or related blood cancers.
Los Angeles, United StatesAge 18+ - Tests natural killer cell therapy after cord blood transplant in blood cancers
Tests natural killer cells after chemotherapy and cord blood transplant in people with leukemia.
Houston, United StatesAge 15 to 80 - Tests asciminib in people newly diagnosed with chronic myeloid leukemia
Tests asciminib, a drug, in adults newly diagnosed with chronic myeloid leukemia.
Houston, United StatesAge 18+ - Asciminib as second treatment for chronic phase chronic myeloid leukemia
Tests asciminib in adults with chronic myeloid leukemia previously treated with one TKI.
Houston, United StatesAge 18+ - Tests modified T cells in people with blood cancers
Tests patient-modified immune cells that target cancer-specific markers in adults with blood cancers.
Bethesda, United StatesAge 18 to 120 - Tests asciminib with chemotherapy and venetoclax in advanced myeloid leukemia
Tests asciminib with chemotherapy and venetoclax in adults with advanced myeloid leukemia.
Houston, United StatesAge 18 to 70 - Imetelstat Maintenance After Stem Cell Transplant for High-Risk Blood Cancers
Tests whether imetelstat is safe in adults with high-risk myeloid cancers after transplant.
Madison, United StatesAge 18 to 80 - Tests Orca-Q donor cell therapy in children receiving blood stem cell transplants
Tests Orca-Q, an engineered donor graft, in children with blood cancers receiving transplants.
Gainesville, United StatesAlso Miami, St. PetersburgUp to age 50 - Donor Immune Cell Infusions Collected After Exercise to Prevent Leukemia Relapse After Transplant
Tests exercise-collected donor cell infusions to prevent relapse after transplant in blood cancers.
Tucson, United StatesUp to age 65 - Cord blood stem cell transplant with chemotherapy in high-risk blood cancers
Tests a donor umbilical cord blood transplant in people with high-risk blood cancers.
Seattle, United StatesAge 0 to 65 - CMV vaccine for stem cell donors to protect transplant patients with blood cancers
Tests a CMV vaccine in stem cell donors for transplant patients.
Atlanta, United StatesAlso Boston, DuarteAge 18 to 75 - Tests a CMV vaccine in stem cell transplant donors and recipients
Tests a CMV vaccine in people receiving a haploidentical stem cell transplant for blood cancers.
Atlanta, United StatesAlso Boston, DuarteAge 18 to 75 - PMD-026 for Myelofibrosis and Related Myeloid Blood Cancers
Tests PMD-026, an oral drug, in adults with myelofibrosis or related blood cancers.
St Louis, United StatesAge 18+
Where treatment stands
Where research stands now
On 11 November 2026, 190 trials and studies of this disease were open. Current trials tested 283 treatments in people: 21 had reached phase 3, the last stage before approval, and 155 phase 2. From November 2025 to November 2026, published studies of treatments were 20 in people, 23 in animals and 52 in the lab. Six medicines had US approval and seven EU approval; one, efbemalenograstim alfa, got its first EU approval, for any use, in March 2024. Health pages say a donor stem cell transplant can cure some people.
We found 11 medicines approved for chronic myeloid leukaemia in the EU, the US, Switzerland or France, and 10 being tested in people.
Approved: 11
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 10
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 2
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 1
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.
Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 54 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for chronic myeloid leukaemia. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
Support organisations
Patient organisations and helplines in United States, for you and your family.
Chronic myeloid leukaemia organisations in United States
- National Cancer Institute – Cancer Information Service (CIS)
NCI's contact center: information specialists answer cancer questions from patients, families and the public by phone, chat and email.
- American Cancer Society
Nationwide US nonprofit helping people who face cancer: research, patient services, early detection, treatment information and education, with a cancer helpline on its site.
- Cactus Cancer Society
Young adult cancer resource and community: support programs for people diagnosed with cancer as young adults.
- Cancer Hope Network
Nonprofit providing free one-on-one support to cancer patients and families by matching them with trained volunteers who have had a similar experience.
- Cancer Nation
Survivor-led US cancer advocacy organization (formerly the National Coalition for Cancer Survivorship) working on quality cancer care and survivorship resources.
- Genetic and Rare Diseases Information Center
NIH information center (GARD) providing reliable information on genetic and rare diseases to patients and families via website and contact center.
- Imerman Angels
Nonprofit offering free one-on-one cancer support and personalized mentoring that connects cancer fighters, survivors and caregivers with someone who has been there.
- Triage Cancer
National nonprofit providing free education on legal and practical issues (insurance, employment, finances) for people with cancer and caregivers.
General support in United States
- 988 Suicide & Crisis Lifeline
US national 24/7 free and confidential lifeline for anyone in suicidal crisis or emotional distress, reachable by calling or texting 988 or by chat.
- MedlinePlus
Free, easy-to-read health information service of the US National Library of Medicine (NIH) on diseases, conditions, drugs and wellness.
International organisations
- DKMS
Finds blood stem cell donors worldwide so that people with blood cancer can have a transplant.
- The Max Foundation
Brings cancer medicines, support groups and patient help to people in over 80 countries.
Offer tissue or data
There are three ways to help research move faster.
Treatments approved outside the EU
Medicines for Chronic myeloid leukaemia approved in the US or Japan that are not approved in the EU.
Checked on 11 Nov 2026 in the official lists of the US (FDA), Japan (PMDA, approvals since April 2004) and the EU (EMA). 4 uncertain matches are left out.
Your health insurer may pay part of the cost, sometimes all of it. This depends on your insurer, your plan and the country, so always ask your insurer before you go. For planned care in the EU, the EEA and Switzerland, ask about form S2.
“Miracle cure” fact checker
Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- CBD (cannabidiol) & Chronic myeloid leukaemia
- Vitamin C (incl. high-dose) & Chronic myeloid leukaemia
- Ivermectin & Chronic myeloid leukaemia
- Fenbendazole & Chronic myeloid leukaemia
About Chronic myeloid leukaemia
A rare, slow-growing cancer of the bone marrow and of the white blood cells it makes.1 Early on there may be no symptoms; later it can cause tiredness, night sweats, weight loss and a swollen tummy.2 The main treatment is targeted medicines called tyrosine kinase inhibitors, which aim to stop the cancer growing.3 It can start at any age but is more common from about 65.1
What is it?
Chronic myeloid leukaemia (CML) is a cancer of the bone marrow, where blood cells are made, and of the white blood cells it makes.1,4 In CML, part of the DNA from one chromosome moves to another chromosome. This change is called the Philadelphia chromosome.4 The ABL1 gene joins the BCR gene to form the BCR::ABL1 fusion gene. This makes the bone marrow produce a protein that causes too many stem cells to become white blood cells.4 It develops slowly, over several years.1
CML is rare.1 It can start at any age, but it is more common from about 65 and rare in children; half of people are 67 or older when they find out.1,4,5 The gene change is not passed on in families.4
The first signs
There may be no symptoms at first.2
- tiredness or weakness, and looking pale;2
- bruising or bleeding easily;2
- a swollen tummy, or pain or fullness under the left ribs;2,4
- night sweats, fever, or losing weight without trying;2,4
- getting ill often, bone aches or headaches.2
Less often, CML causes painful erections, or erections that do not go down.2
How doctors find out
Your family doctor examines you, looks for bruises and swellings, and may arrange a blood test.2 A blood specialist (haematologist) then does more blood tests and a bone marrow biopsy: a small sample is taken with a needle, usually with a local anaesthetic.6 Genetic tests on your blood and bone marrow check for changes such as the Philadelphia chromosome. You may also have an ultrasound scan.6,4 Results can take a few weeks.6 The tests show the phase of CML: chronic, accelerated or blast.6
Current treatment
Chronic-phase CML is treated with a tyrosine kinase inhibitor (asciminib, imatinib, dasatinib, nilotinib or bosutinib); a donor stem cell transplant is an option for some.Source: NCI PDQ
Will it get worse?
CML is usually treatable.1 It has three phases, chronic, accelerated and blast, depending on how many immature cells (blasts) are in the blood and marrow.6,4 How it goes depends on the phase, your age and your general health.4 With today's targeted medicines, more than 9 in 10 people with newly diagnosed chronic-phase CML are alive 10 years later, and most people are expected to live close to a normal lifespan.5
Medicines: what helps, and what to watch for
The main treatment is a group of targeted medicines called tyrosine kinase inhibitors (TKIs), such as imatinib, dasatinib, nilotinib, bosutinib or asciminib.3,4,5 They aim to stop the cancer growing.3 Chemotherapy is used for some people, for example to control symptoms or in the blast phase.3
Good to know:
- There are many TKIs. If one gives you side effects or stops working, your specialist can switch you to another;3
- Some tests may be repeated to see how well the treatment is working. Decisions about whether to continue, change or stop treatment may be based on the results.4
- It is not yet clear whether TKIs can be stopped. People with a long, very deep response are the best candidates, but about half of those who stop see the leukaemia come back;5
- Weight-loss surgery may block some of the TKI tablets from being absorbed, so they may work less well.4,5
A transplant, for some people
A stem cell transplant from a donor replaces damaged blood cells with healthy ones after strong chemotherapy.3,4 It may be considered if TKIs stop controlling the leukaemia, or in the accelerated or blast phase.3 It is the only treatment that reliably cures CML: about half to 7 in 10 people who have it in the chronic phase seem to be cured.5
Is there a cure?
CML usually develops slowly and is usually treatable. With targeted medicines, most people are expected to live close to a normal lifespan.1,5 A donor stem cell transplant can cure some people.5 Clinical trials are testing new treatments and new ways to use current ones.4
Median survival
Expected to be close to a normal lifespan for most people with today's medicinesSource: NCI PDQ, 2025
Measured in: Most patients, with tyrosine kinase inhibitors (a projection)
The figures behind it
NCI PDQ (health professional version): with tyrosine kinase inhibitors the median survival is projected to approach normal life expectancy for most patients; 10-year event-free and overall survival with first-line TKIs exceed 90%. Median age at diagnosis 67 years.
Sources
Written in plain words by Frontlight from these pages:
- NHS: Chronic myeloid leukaemia – What is chronic myeloid leukaemia?
- NHS: Chronic myeloid leukaemia – Symptoms
- NHS: Chronic myeloid leukaemia – Treatment
- NCI PDQ: Chronic Myeloid Leukemia Treatment (PDQ®) – Patient Version
- NCI PDQ: Chronic Myeloid Leukemia Treatment (PDQ®) – Health Professional Version
- NHS: Chronic myeloid leukaemia – Tests and next steps